AI Assistant
Blog
Pricing
Log In
Sign Up
EGFL7 drives the evolution of resistance to EGFR inhibitors in lung cancer by activating NOTCH signaling
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
